Today: 4 February 2026
Subscribe
Browse Category

TSX:TD.TO News 4 December 2025

TD Bank Stock Soars After Q4 2025 Earnings Beat and Dividend Hike: Is Toronto-Dominion Still a Buy for 2026?

TD Bank Stock Soars After Q4 2025 Earnings Beat and Dividend Hike: Is Toronto-Dominion Still a Buy for 2026?

On December 4, 2025, Toronto-Dominion Bank stock (Toronto: TD.TO, New York: TD) pushed near fresh 52‑week highs after the bank reported better‑than‑expected Q4 2025 earnings, raised its dividend, and reaffirmed ambitious growth targets for 2026 and beyond.  TD Stories At the same time, investors are still weighing the aftershocks of TD’s US$3 billion anti‑money‑laundering (AML) settlement in the United States and a multi‑year compliance overhaul that…
4 December 2025
····

Stock Market Today

  • Actinogen Medical and Top ASX Penny Stocks Show Potential Amid Market Headwinds
    February 4, 2026, 3:40 PM EST. The Australian stock market faces pressure from a Reserve Bank rate hike and international tech sell-offs, with ASX 200 futures hinting at a downturn. Yet, ASX penny stocks continue to offer investment opportunities due to their low price points and growth potential. Actinogen Medical (ASX:ACW), a pre-revenue biotechnology firm valued at A$153.2 million, is advancing its Alzheimer's treatment trial and recently secured A$17 million in funding. Despite current unprofitability, Actinogen's innovative approach could spur future revenue growth. Brisbane Broncos Limited (A$181.38 million market cap) operates debt-free in sports management, underlining stability. These stocks exemplify how smaller firms with strong fundamentals may thrive even amid broader market uncertainty.
Go toTop